|
ERYSENG PARVO
|
-
|
EU/2/14/167/007
|
Laboratorios Hipra S.A., Spānija
|
QI09AL01
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Inactivated Erysipelothrix rhusiopathiae ,Inactivated swine parvovirus strain
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Laboratorios Hipra S.A., Spānija
|
| Date of authorisation/renewal: |
05-Oct-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/14/167/007 |
|
1 |
PET pudele, 125 deva |
-
|
|
|
FRONTPRO
|
11.3 mg
|
EU/2/19/240/004
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QP53BE01
|
Dogs 2–4 kg
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Afoxolaner
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
Merial, Francija
|
| Date of authorisation/renewal: |
20-May-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/240/004 |
11,3 mg |
15 |
PVH/Aclar/Al blisteris, 1 tablete |
-
|
|
|
Solensia
|
7 mg/ml
|
EU/2/20/269/002
|
Zoetis Belgium S.A., Beļģija
|
QN02BG90
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Frunevetmab
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Belgium S.A., Beļģija
|
| Date of authorisation/renewal: |
17-Feb-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/20/269/002 |
7 mg/ml |
2 |
Stikla flakons, 1 ml |
-
|
|
|
Porcilis PCV M Hyo ID
|
-
|
EU/2/24/319/004
|
Intervet International B.V., Nīderlande
|
QI09AL08
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Porcine circovirus type 2, ORF2 capsid protein
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
30-Aug-2024
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/24/319/004 |
|
10 |
PET flakons, 50 deva |
-
|
|
|
MELOXIDYL
|
1.5 mg/ml
|
EU/2/06/070/003
|
Ceva Sante Animale., Francija
|
QM01AC06
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for oral use
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Ceva Sante Animale, Francija;Vetem SpA, Itālija
|
| Date of authorisation/renewal: |
15-Jan-2007
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/06/070/003 |
1,5 mg/ml |
1 |
Flakons, 100 ml |
-
|
|
|
Contacera
|
20 mg/ml
|
EU/2/12/144/002
|
Zoetis Belgium S.A., Beļģija
|
QM01AC06
|
cattle; pigs; horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Eurovet Animal Health B.V., Nīderlande;Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
|
| Date of authorisation/renewal: |
15-Nov-2017
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/12/144/002 |
20 mg/ml |
1 |
Flakons, 50 ml |
-
|
|
|
QUADRISOL
|
100 mg/ml
|
EU/2/97/005/005
|
VETCOOL B.V., Nīderlande
|
QM01AE90
|
horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
Oral Gel
|
| International name (active substance): |
Vedaprofen
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Purna Pharmaceuticals N.V., Beļģija
|
| Date of authorisation/renewal: |
13-Nov-2007
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/97/005/005 |
100 mg/ml |
3 |
Pilnšļirce, 30 ml |
-
|
|
|
VEPURED
|
-
|
EU/2/17/214/002
|
Laboratorios Hipra S.A., Spānija
|
QI09AB02
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Recombinant verotoxin 2e of E. coli
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Laboratorios Hipra S.A., Spānija
|
| Date of authorisation/renewal: |
22-Jul-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/17/214/002 |
|
1 |
Polietilēna flakons, 50 deva |
-
|
|
|
Rhiniseng
|
-
|
EU/2/10/109/008
|
Laboratorios Hipra S.A., Spānija
|
QI09AB04
|
sows; gilt
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Pasteurella multocida Serotype D,Inactivated Bordetella bronchiseptica
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Laboratorios Hipra S.A., Spānija
|
| Date of authorisation/renewal: |
15-Sep-2015
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/10/109/008 |
|
1 |
Plastmasas pudele, 100 ml |
-
|
|
|
Trilocur
|
10 mg/ml
|
EU/2/24/312/001
|
Emdoka bvba, Beļģija
|
QH02CA01
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for oral use
|
| International name (active substance): |
Trilostane
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
06-May-2024
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/24/312/001 |
10 mg/ml |
1 |
Polietilēna pudele, 30 ml |
-
|
|
|
APOQUEL
|
3.6 mg
|
EU/2/13/154/020
|
Zoetis Belgium S.A., Beļģija
|
QD11AH90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
film-coated tablets
|
| International name (active substance): |
Oclacitinib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Belgium S.A., Beļģija;Pfizer Italia S.R.L., Itālija
|
| Date of authorisation/renewal: |
13-Dec-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/13/154/20 |
3,6 mg |
5 |
Blisteris, 10 tablete |
-
|
|
|
Poulvac E.Coli
|
-
|
EU/2/12/140/001
|
Zoetis Belgium S.A., Beļģija
|
QI01AE04
|
turkeys; chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
Lyophilisate for suspension for spray vaccination
|
| International name (active substance): |
Live aroA gene deleted Escherichia coli, type O78, strain EC34195
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Manufacturing & Research Spain S.L., Spānija
|
| Date of authorisation/renewal: |
15-Jun-2012
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/12/140/001 |
|
1 |
Stikla flakons, 2500 deva |
-
|
|
|
Stronghold
|
360 mg
|
EU/2/99/014/015
|
Zoetis Belgium S.A., Beļģija
|
QP54AA05
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Selamectin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Pfizer Service Company bvba, Beļģija
|
| Date of authorisation/renewal: |
07-Apr-2015
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/99/014/015 |
360 mg/ml |
3 |
Polipropilēna pipete, 1 deva |
-
|
|
|
Ingelvac CircoFLEX
|
-
|
EU/2/07/079/013
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QI09AA07
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Inactivated recombinant Porcine Circovirus type 2
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
| Date of authorisation/renewal: |
13-Apr-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/07/079/013 |
|
12 |
TwistPak pudele, 10 ml |
-
|
|
|
Poulvac AE
|
-
|
V/I/22/0039
|
Zoetis Polska Sp.z.o.o., Polija
|
QI01AD02
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate for suspension in drinking water
|
| International name (active substance): |
Avian encephalomyelitis virus
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Manufacturing Research Spain S L, Spānija
|
| Date of authorisation/renewal: |
04-Nov-2022
|
| Marketing authorisation valid until: |
03-Nov-2027
|
| Marketing authorisation procedure: |
I
|
| Package leaflet: |
[DOCX] 09042025LI (09-Apr-2025)
|
| Labelling text: |
See products section
|
| Summary of product characteristics: |
-
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/I/22/0039-01 |
|
10 |
Flakons, 1000 deva |
[PDF]
|
|
|
Nobilis Multriva IBm+ND
|
-
|
EU/2/25/342/001
|
Intervet International B.V., Nīderlande
|
QI01AA10
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
02-Jun-2025
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/25/342/001 |
|
1 |
PET pudele, 300 ml |
-
|
|
|
Credelio Plus
|
-
|
EU/2/21/271/016
|
Elanco GmbH, Vācija
|
QP54AB51
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Lotilaner, Milbemycin oxime
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Elanco France S.A.S, Francija
|
| Date of authorisation/renewal: |
14-Apr-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/21/271/016 |
|
1 |
Al/Al blisteris, 18 tablete |
-
|
|
|
Trilocur
|
10 mg/ml
|
EU/2/24/312/002
|
Emdoka bvba, Beļģija
|
QH02CA01
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for oral use
|
| International name (active substance): |
Trilostane
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
06-May-2024
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/24/312/002 |
10 |
1 |
Polipropilēna pudele, 90 ml |
-
|
|
|
Advocate Spot-on šķīdums vidējiem suņiem
|
-
|
EU/2/03/039/043
|
Bayer Animal Health , Vācija
|
QP54AB52
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Moxidectin,Imidacloprid
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
KVP Pharma + Veterinar Produkte GmbH, Vācija
|
| Date of authorisation/renewal: |
16-Jul-2007
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/03/039/043 |
|
1 |
Pipete, 1 ml |
-
|
|
|
Coxatab
|
100 mg
|
EU/2/22/286/016
|
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
QM01AH90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
Chewable tablet
|
| International name (active substance): |
Firocoxib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
| Date of authorisation/renewal: |
12-Aug-2022
|
| Marketing authorisation valid until: |
11-Aug-2027
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/22/286/016 |
100 mg/tabl. |
1 |
alumīnija/PVC/PE/PVDC blisteris, 30 tablete |
-
|
|